Summary: Human urinary kailikrein (EC 3.4.21.8) was purified to electrophoretically homogeneity by gel filtration on Sephadex G-100, followed by affinity chromatography on aprotinin-Sepharose. The molecular weight, estimated by gel filtration, is 64,000 Daltons, by dodecyl sulfate electrophoresis 45,000 Daltons and 29,000 Daltons, and it is microheterogeneous on electrofocusing, yielding isoelectric point values of 3.8, 3.9 and 4.05. The kinetic constants for hydrolysis of BzArgOEt, TosArgOMe, CbzTyrONp, and human HMW-kininogen were determined. Benzamidine and aprotinin are competitive inhibitors of human urinary kailikrein.
Introduction (20) and men with primary hyperaldosteronism (21) v, « , s»,*, *> * ~« «Nix j . j t.· _ h ave higher urinary kailikrein levels. A role of kailikrein Kallikreins (EC 3.4.21.8)') are endopeptidases, which fa ^ ^ rf sodjum excretion fc are found in the blood, tissues, and urine of several spe-(22^,4) Jn patients show -ng reaction tQ kjdney trans . cies . (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . They liberate kinins (biologically active plant> Ufinary kallikrein Ievels are lower (25) md vaso . polypeptides) from kininogen, which is a part of the duators such as p rosta giandins, acetylcholine, bradykinin a 2 -globulin fraction of the plasma.
and i sop roterenol increase urinary kallikrein excretion Since the discovery of kallikrein in 1926 (14) , many (26-3 1) . Recently, some investigators have shown that investigators have shown that the kidney kallikrein plays Binary kallikrein levels are decreased in glomerular basean important role in the physiological processes of the ment membrane nephritis (32) . kidney. In essential hypertension, Elliot &Nuzum (15) and Werle & Korsten (16) found lower than normal Urinar y kallikrein is normally measured by the cleavage levels of kallikrein in urine. Work byMorgolius et at.
of synthetic acyl-arginine esters. This is not a very (17-1 9) has also shown a decreased excretion of ' s P ecific method ' since there «e other proteases in urine urinary kallikrein in vascular hypertension. In contrast, ^th the same esterolytic activity. In this and the followanimals with deoxycorticosteron*induced hypertension J* P a f r ™ «P«t the isolation of human urmary kalhkrein by affinity chromatography, the preparation of antibodies against it, and the specific determination by (EC 3.4 (36) , and Kininogen (33) as described.
Kinin activity
Bradykinin or kinin activity was assayed on the rat uterus as described by Mann (33) . Bradykinin served as a reference standard for kinin activity.
Protein concentration was determined as described by Richterich (37) . Standard serum (E. Merck, Darmstadt) was used as a reference.
Electrophoresis
Polyacrylamide gel electrophoresis was performed in a DESAGA flat gel apparatus. To check the purity of the preparation, gel no. 1 a (75 g/1 acrylamide gel, pH 8.9) according to Maurer (38) was employed.
Molecular weight
Molecular weight estimation was performed after reduction of -S-S-bonds by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (39) . Coomassie Blue R-250 (Serva, Heidelberg) was used for staining. The determination of the molecular weight by gel filtration was perfof med on a Sephadex G 100 column (140 X 1.8 cm).
Aprotinin-Sepharose 4B
The affinity absorbent was synthesised according to 1. c. (40) .
Electrofocusing
Human urinary kallikrein was submitted to electrofocusing in ampholine in a pH gradient from 3 to 5, according to (41) .
halation of human urinary kallikrein
Isolation of human urinary kallikrein was achieved by the following procedure: 301 urine of male subjects were dialysed against running water for 24 h and then lyophilized. The lyophilized urine was suspended under gentle stirring (20 min) in 70 ml dist. water at 0,°,C. The suspension was centrifuged (8000#), the supernatant 2 
) Abbreviations
BzArgOEt: N a -benzoyl-L-arginine ethyl ester TosArgOMe: Tosyl-/,-arginine methyl ester CbzTyrONp: Carbobenzoxy-I-tyrosine-p-nitrophenyl ester HMW-kininogen: High molecular weight kininogen SDS: Sodium dodecylsulfate (30 ml) was applied to a water cooled Sephadex G-100 column (60 X 4.3 cm) and eluted with dist. water, (flow rate 50 ml/h; fractions of 12 ml were collected).
Affinity chromatography
The kallikrein-containing fractions were combined, lyophilized, dissolved in 4 ml phosphate buffer (0.025 mol/1 Na 2 HP0 4 ,0.025 mol/1 KH 2 P0 4 , 0.75 mol/1 NaCl) pH 7.0, and applied to a aprotininSepharose 4 B column (15X1 cm) equilibrated with phosphate buffer. The column was washed with phosphate buffer, and eluted with 50 ml of the same buffer containing 1 mol/1 benzamidine hydrochloride. The eluted fractions were dialysed against 501 dist. water for 48 h, lyophilized, dissolved in 0.05 mol/1 ammonium acetate buffer pH 7.0, applied to a Sephadex G-25 column (70 X 1.5 cm), equilibrated with the same buffer and eluted with 0.05 mol/1 ammonium acetate buffer pH 7.0 (flow rate 30 ml/h; fractions of 2.5 ml were collected).
The kallikrein-containing fractions were combined, lyophilized, dissolved in 5 ml 0.05 mol/1 ammonium acetate buffer pH 7.4 and applied to a Sephacryl S-200 superfine column, equilibrated with the same buffer.
Results and Discussion
The protein was eluted with 0.05 mol/1 ammonium acetate buffer pH 7.4 and the fractions appeared homogeneous on polyacrylamide gel electrophpresis. In this way human urinary kallikrein was purified as shown in table 1.
The molecular weight was estimated by gel filtration to be 64000 ( fig. 1.) . By dodecylsulfate polyacrylamide gel electrophoresis values of 45000 and 29000 ( fig. 2) were obtained. In figure 3 , and figure 4 the pH-optimum and the heat stability of human urinary kallikrein are shown.
When human urinary kallikrein was submitted to'electrofocusing in ampholine in a pH gradient from 3 to 5, three components active on CbzTyrONp were detected. The isoelectric point values are 3.8, 3.9, and 4.09 as shown in figure 5.
Human urinary kallikrein is competitively inhibited by benzamidine and aprotinin. The kinetic data are given in table 2.
A kallikrein from human urine was purified for the first time by Moriya in 1963 (1) using DEAE-Sephadex A^SO as an initial step. In the present work, the important purification step is the aprotinin^Sepharose 4B affinity chromatography. After separation of the bile pigments by gel filtration, the fractions containing kallikrein activity are very heterogeneous and it is possible to remove nearly all the proteins from the kallikrein by affinity chromatography. the gel filtration on Sephacryl S-200 yields a purified human urinary kallikrein, which is used for the preparation of antibodies.
The enzyme is considered pure by the following criteria: it yields a single peak on rechromatography in a Sephacryl S-200 column, with constant specific activity and it shows single band upon eleetrophoresis in polyacryl mide at 75 g/1.
After incubation of the polyacrylamide gel with CbzTyrONp at pH 8.0, the region of human urinary kallikrein shows esterolytic activity.
After gel filtration on Sephadex G-100, the kallikrein activity is increased. Two possible explanations of this phenomenon can be suggested. Either a kallikrein-inhibitor complex is dissociated during the elution, or a precursor is activated by the procedure.
It is interesting that the quotients of the specific activities are constant during the isolation steps for CbzTyrONp and kiriinogen, but not for BzArgOEt and kininogen. These characteristics indicate that there are other proteinases in urine with esterolytic activities on BzArgOEt.
